Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors

Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors

© 2019 Objectives: The risk of kidney dysfunction on the WHO recommended first line regimens containing tenofovir disoproxil fumarate (TDF) without protease inhibitors (PI) remains unclear in Asian patients, especially those with low body weight. Methods: Using data collected in a multicenter clinic...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Geoffroy Liegeon, Linda Harrison, Anouar Nechba, Guttiga Halue, Sukit Banchongkit, Ampaipith Nilmanat, Naruepon Yutthakasemsunt, Panita Pathipvanich, Suchart Thongpaen, Rittha Lertkoonalak, Thomas Althaus, Marc Lallemant, Jean Yves Mary, Gonzague Jourdain
التنسيق:	دورية
منشور في:	2019
الموضوعات:	Medicine
الوصول للمادة أونلاين:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85071115772&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/66732
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
بواسطة: David V. Glidden, وآخرون
منشور في: (2018)

Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic review
بواسطة: Marieke Bierhoff, وآخرون
منشور في: (2020)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Temofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Temofovir Disoproxil Fumarate Monotherapy
بواسطة: Vera E. Bukkems, وآخرون
منشور في: (2020)

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2020)

Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Pharmacokinetics of Atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate
بواسطة: Torsak Bunupuradah, وآخرون
منشور في: (2018)

Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate
بواسطة: Phuphuakrat A.
منشور في: (2023)

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: A randomized, directly observed pharmacokinetic trial (target study)
بواسطة: Paul K. Drain, وآخرون
منشور في: (2020)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
بواسطة: Marc M. Solomon, وآخرون
منشور في: (2018)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
بواسطة: Tavitiya Sudjaritruk, وآخرون
منشور في: (2018)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
بواسطة: Marc M. Solomon, وآخرون
منشور في: (2018)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
بواسطة: Solomon M.M., وآخرون
منشور في: (2014)

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents
بواسطة: Tavitiya Sudjaritruk, وآخرون
منشور في: (2018)

Tenofovir Disoproxil Fumarate (TDF) Prenatal Sebagai Pelengkap Tatalaksana Pencegahan Transmisi Vertikal Virus Hepatitis B
بواسطة: Avianita Dewi Kusumawardhani
منشور في: (2020)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Recovery of renal function after early versus late switching of tenofovir disoproxil fumarate in people living with HIV with renal insufficiency
بواسطة: Supawadee Suppadungsuk, وآخرون
منشور في: (2022)

Recovery of renal function after early versus late switching of tenofovir disoproxil fumarate in people living with HIV with renal insufficiency
بواسطة: Suppadungsuk S.
منشور في: (2023)

Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review
بواسطة: Bagus Setyoboedi, Bagus, وآخرون

Incidence rate and time to occurrence of renal impairment and chronic kidney disease among thai hiv-infected adults with tenofovir disoproxil fumarate use
بواسطة: Jirayu Visuthranukul, وآخرون
منشور في: (2022)

Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis
بواسطة: Marieke Bierhoff, وآخرون
منشور في: (2022)

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
بواسطة: Alex Carballo-Diéguez, وآخرون
منشور في: (2018)

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
بواسطة: Alex Carballo-Diéguez, وآخرون
منشور في: (2018)

Vitamin D and Calcium Supplement Attenuate Bone Loss among HIVInfected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/ Efavirenz: An Open-Label, Randomized Controlled Trial
بواسطة: Patawee Boontanondha, وآخرون
منشور في: (2020)

Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus
بواسطة: Nicolas Salvadori, وآخرون
منشور في: (2019)

Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living with HIV: Week 24 Results from IMPAACT 2014
بواسطة: Melvin A.J.
منشور في: (2023)

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
بواسطة: Avihingsanon A.
منشور في: (2023)

Erratum : Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight band dosing(Pediatr Infect Dis J. (2015)34(392-397))
بواسطة: Kulkanya Chokephaibulkit
منشور في: (2018)

Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
بواسطة: Gonzague Jourdain, وآخرون
منشور في: (2018)

Raltegravir 1200 mg once daily vs 400 mg twice daily, with emtricitabine and tenofovir disoproxil fumarate, for previously untreated HIV-1 infection: Week 96 results from ONCEMRK, a randomized, double-blind, noninferiority trial
بواسطة: Pedro Cahn, وآخرون
منشور في: (2019)

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
بواسطة: Pedro Cahn, وآخرون
منشور في: (2018)

Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
بواسطة: Jourdain G., وآخرون
منشور في: (2017)

Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure
بواسطة: Gonzague Jourdain, وآخرون
منشور في: (2018)

Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with Tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study
بواسطة: Connie Celum, وآخرون
منشور في: (2018)

Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with Tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study
بواسطة: Connie Celum, وآخرون
منشور في: (2018)

Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with Tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study
بواسطة: Celum C., وآخرون
منشور في: (2017)

Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: A Bayesian analysis
بواسطة: Nicole Ngo-Giang-Huong, وآخرون
منشور في: (2018)